Humane Genomics
Private Company
Platform to engineer cancer killing viruses using synthetic biology.
Biotechnology Research
New York, NY
2-10 employees
Founded 2019
About Humane Genomics
Humane Genomics is a biotechnology company dedicated to developing next-generation oncolytic viruses for cancer therapy. Leveraging its advanced synthetic biology and virology platform, the company designs and engineers precision therapies to seek out and eliminate cancer cells. Humane Genomics partners with biotech companies, clinicians, and scientific research organizations to advance cancer treatment, including first-in-class solutions for pediatric liver cancer.
Company Classification
Customer Types
B2B
Business Models
ProductsServicesLicensing
Product & Service Types
Oncolytic Virus TherapiesSynthetic Biology PlatformsViral Engineering R&D Services
Funding
Total Funding
$125.0K
No. of Funding Rounds
3
Customers
| Customer | Success Story | Source |
|---|---|---|
| Partnered with Humane Genomics on Hepatoblastoma research, sponsoring abstract submission and a poster presentation at the AACR 2023 conference, and providing a platform for liver cancer studies. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos